ZYBT Stock Summary and Trading Ideas (Zhengye Biotechnology Holding Limited - Class A | NASDAQ:ZYBT)

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.

Zhengye Biotechnology Holding Limited - Class A trades on the NASDAQ stock market under the symbol ZYBT.

As of September 4, 2026, ZYBT stock price declined to $1.61 with 32,133 million shares trading.

ZYBT has a beta of 1.37, meaning it tends to be more sensitive to market movements. ZYBT has a correlation of 0.01 to the broad based SPY ETF.

ZYBT has a market cap of $76.30 million. This is considered a Micro Cap stock.

ZYBT has underperformed the market in the last year with a price return of -79.5% while the SPY ETF gained +19.8%. However, in the short term, ZYBT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +94.0% vs +2.0% return in SPY. But in the last 2 weeks, ZYBT shares have been beat by the market, returning -21.1% compared to an SPY return of +0.6%.

ZYBT support price is $1.48 and resistance is $1.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZYBT shares will trade within this expected range on the day.